News & Events
16 September 2021
Halfway through recruitment!
We are now halfway through recruiting patients for the EFFECT study! This week, the 175th participant agreed to participate in the study. As a result, we have reached the EU-milestone. A big thanks to all participants and staff, who are all highly committed to the project.
27 August 2021
Poland recruited their 10th participant
Due to the Corona pandemic, Poland was not able to start recruitment yet. They started recruiting patients in March and already recruited the 10th participant by the end of August. Keep up the good work! In the meanwhile, all sites are up and running and we hope to be halfway through recruitment very soon.
6 July 2021
Live-remote training during the Corona pandemic
Because training centers were closed in Germany, the Heidelberg University Hospital developed a live-remote exercise intervention for participants of the EFFECT trial. Patients successfully follow the study intervention from their living rooms. They train as hard as in-person and enjoy the interaction with the trainer and the other participants.

PREFERABLE consists of an international consortium of nine academic partners, one cutting edge game development and software engineering SME , one science-driven clinical trial management company and one European patient organisation (EUROPA DONNA – The European Breast Cancer Coalition, representing 47 countries throughout Europe). The partners are from seven countries in the Netherlands, Germany, Sweden, Poland, Spain, Italy and Australia and are coordinated by the University Medical Center Utrecht, the Netherlands.